drugset / Trial / NCT06838949
A Clinical Study on the Efficacy and Safety of Herombopag in the Treatment of Senile Primary ITP
NaSingle-groupOpen-labelTreatment
Summary
The objective of this study was to evaluate the efficacy and safety of Herombopag in the treatment of elderly patients with ITP.
Timeline
- Start
- 2025-03-03
- Primary completion
- 2026-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RAFUTROMBOPAG | Other / unclassified | 5 mg | Oral |
Indications
No indication recorded.